Novartis New Organizational Model
Now creating a simplified organizational model designed to support
our innovation, growth and productivity ambitions
1
Integrated IM1 business,
with US and International
at ECN²
Increase focus and agility,
drive synergies, leverage
scale for growth drivers,
rapidly deploy technology
across IM, and achieve a
top 5 position in the US
2
New Strategy & Growth
function
That aligns and drives
end-to-end enterprise
portfolio needs for growth
across internal and external
pipeline opportunities
3
Single Operations unit
and integrated global
G&A functions
To realize economies of
scale/drive productivity,
ensure success of enterprise
technology projects and
optimize G&A functions
1. IM Innovative Medicines 2. ECN Executive Committee of Novartis
7
NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION
NOVARTIS | Reimagining MedicineView entire presentation